TIZONA

Serial Number 88241606
Registration 6335584
700

Registration Progress

Application Filed
Dec 26, 2018
Under Examination
Jun 25, 2019
Approved for Publication
Apr 30, 2019
Published for Opposition
Apr 30, 2019
Registered
Apr 27, 2021

Trademark Image

TIZONA

Basic Information

Serial Number
88241606
Registration Number
6335584
Filing Date
December 26, 2018
Registration Date
April 27, 2021
Published for Opposition
April 30, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 27, 2021
Registration
Registered
Classes
005 042

Rights Holder

TIZONA THERAPEUTICS, INC.

03
Address
4000 Shoreline Court, Suite 200
South San Francisco, CA 94080

Ownership History

TIZONA THERAPEUTICS, INC.

Original Applicant
03
South San Francisco, CA

TIZONA THERAPEUTICS, INC.

Owner at Publication
03
South San Francisco, CA

TIZONA THERAPEUTICS, INC.

Original Registrant
03
South San Francisco, CA

Legal Representation

Attorney
Sharon R Smith

USPTO Deadlines

Next Deadline
635 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-04-27)
Due Date
April 27, 2027
Grace Period Ends
October 27, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

31 events
Date Code Type Description Documents
Apr 27, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 26, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Mar 25, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Mar 25, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 25, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 25, 2021 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Sep 30, 2020 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Sep 30, 2020 GNFR O FINAL REFUSAL E-MAILED Loading...
Sep 30, 2020 CNFR W SU - FINAL REFUSAL - WRITTEN Loading...
Sep 9, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 9, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 9, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 4, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 4, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 4, 2020 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Jul 12, 2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 12, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 23, 2020 IUAF S USE AMENDMENT FILED Loading...
Jun 23, 2020 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 24, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 20, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 20, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 20, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 25, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 30, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 30, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 10, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 19, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 19, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 16, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 29, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations and compounds for modulation of the immune system and the tumor microenvironment
First Use Anywhere: May 16, 2016
First Use in Commerce: Mar 11, 2019
Class 042
research and development of pharmaceuticals and compounds for the treatment of cancer and autoimmune diseases; research and development of pharmaceuticals and compounds for modulation of the immune system and the tumor microenvironment
First Use Anywhere: May 16, 2016
First Use in Commerce: May 16, 2016

Classification

International Classes
005 042